TBWA wins three global Merck brands

Merck KGaA has tapped TBWA on three of its consumer healthcare brands: Nasivin, Femibion and Flexagil.

TBWA will handle global communication strategies for each of the brands. The campaigns will debut globally in 2009, according to a company statement.

Neither company responded to inquiries about the assignment. In the statement, Hubertus von Lobenstein, CEO TBWA\Group Germany, said of the wins: “It shows the value of a great team, the international experience as well as the power of our fundamental idea: Disruption.”

Merck's global operating activities function under the umbrella Merck KGaA of Germany, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%, according to the statement. Merck & Co., the US subsidiary, became an independent company in 1917.

You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.